Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mertzlufft

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Hamostaseologie|December 15, 2010
[Acquired von Willebrand's disease type 2A following arteriovenous fistula for haemodialysis?]K Leimkühler, F Bach, S Kuhlmann, et al.
Anaesthesia|March 1, 1988
Prolonged anaesthesia with isoflurane and halothane. Effects on hepatic functionJ P Jantzen, P P Kleemann, P K Witton, et al.
Anesthesia and Analgesia|July 27, 2000
Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systemsA Koster, F Merkle, R Hansen, et al.
Anesthesiology|February 15, 2001
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofibanA Koster, M Kukucka, F Bach, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2000
Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devicesA Koster, S Sänger, R Hansen, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 15, 2001
Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devicesA Koster, M Loebe, R Sodian, et al.
Der Anaesthesist|February 26, 2005
[A factorial trial of six interventions for the prevention of postoperative nausea and vomiting]C C Apfel, A Bacher, A Biedler, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Hamostaseologie|December 15, 2010
[Acquired von Willebrand's disease type 2A following arteriovenous fistula for haemodialysis?]K Leimkühler, F Bach, S Kuhlmann, et al.
Anaesthesia|March 1, 1988
Prolonged anaesthesia with isoflurane and halothane. Effects on hepatic functionJ P Jantzen, P P Kleemann, P K Witton, et al.
Anesthesia and Analgesia|July 27, 2000
Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systemsA Koster, F Merkle, R Hansen, et al.
Anesthesiology|February 15, 2001
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofibanA Koster, M Kukucka, F Bach, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2000
Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devicesA Koster, S Sänger, R Hansen, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 15, 2001
Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devicesA Koster, M Loebe, R Sodian, et al.
Der Anaesthesist|February 26, 2005
[A factorial trial of six interventions for the prevention of postoperative nausea and vomiting]C C Apfel, A Bacher, A Biedler, et al.
Pageof 10